Literature DB >> 7941350

Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A.

S Boomer1, P Gasper, L R Whalen, J Overbaugh.   

Abstract

Proviruses were cloned directly from a cat that developed neurological disorders approximately 28 months after inoculation with a molecularly cloned, minimally pathogenic subgroup A feline leukemia virus (FeLV-A). In addition to FeLV-A proviruses that were nearly identical to the inoculated virus, we detected a subgroup B-like variant in brain, bone marrow, and lymph node that apparently had acquired the major portion of its extracellular envelope gene (gp70) from endogenous FeLV-related sequences. A similar recombinant was also detected, by PCR, at low levels in bone marrow from an early time postinfection (2.5 months). A full-length proviral variant with this recombinant structure cloned from brain tissue encoded a replication-defective virus. A chimera encoding the 5' gag-pol portion of FeLV-A and the 3' env-LTR portion of the defective brain-derived clone was replication-competent and had the extended host range properties of FeLV-B.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7941350     DOI: 10.1006/viro.1994.1597

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.

Authors:  S Boomer; M Eiden; C C Burns; J Overbaugh
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.

Authors:  S R Gwynn; F C Hankenson; A S Lauring; J L Rohn; J Overbaugh
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Differential pathogenicity of two feline leukemia virus subgroup A molecular clones, pFRA and pF6A.

Authors:  A J Phipps; H Chen; K A Hayes; P Roy-Burman; L E Mathes
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

4.  Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants.

Authors:  A S Lauring; M M Anderson; J Overbaugh
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.

Authors:  M M Anderson; A S Lauring; S Robertson; C Dirks; J Overbaugh
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A.

Authors:  Ramon Mendoza; Maria M Anderson; Julie Overbaugh
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Pathogenicity induced by feline leukemia virus, Rickard strain, subgroup A plasmid DNA (pFRA).

Authors:  H Chen; M K Bechtel; Y Shi; A Phipps; L E Mathes; K A Hayes; P Roy-Burman
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  Substitution of a single amino acid residue is sufficient to allow the human amphotropic murine leukemia virus receptor to also function as a gibbon ape leukemia virus receptor.

Authors:  M V Eiden; K B Farrell; C A Wilson
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  Disruption of thiamine uptake and growth of cells by feline leukemia virus subgroup A.

Authors:  Ramon Mendoza; A Dusty Miller; Julie Overbaugh
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

10.  Simian sarcoma-associated virus fails to infect Chinese hamster cells despite the presence of functional gibbon ape leukemia virus receptors.

Authors:  Y T Ting; C A Wilson; K B Farrell; G J Chaudry; M V Eiden
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.